Bin Xu
Bin Xu
Verified email at
Cited by
Cited by
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
I Landa, T Ibrahimpasic, L Boucai, R Sinha, JA Knauf, RH Shah, S Dogan, ...
The Journal of clinical investigation 126 (3), 1052-1066, 2016
The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease
M Fahnestock, B Michalski, B Xu, MD Coughlin
Molecular and Cellular Neuroscience 18 (2), 210-220, 2001
Dissecting anaplastic thyroid carcinoma: a comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases
B Xu, T Fuchs, S Dogan, I Landa, N Katabi, JA Fagin, RM Tuttle, ...
Thyroid 30 (10), 1505-1517, 2020
Genomic landscape of poorly differentiated and anaplastic thyroid carcinoma
B Xu, R Ghossein
Endocrine pathology 27, 205-212, 2016
Biallelic DICER1 mutations occur in Wilms tumours
MK Wu, N Sabbaghian, B Xu, S Addidou‐Kalucki, C Bernard, D Zou, ...
The Journal of pathology 230 (2), 154-164, 2013
Validation of a digital pathology system including remote review during the COVID-19 pandemic
MG Hanna, VE Reuter, O Ardon, D Kim, SJ Sirintrapun, PJ Schüffler, ...
Modern Pathology 33 (11), 2115-2127, 2020
A proposal to redefine close surgical margins in squamous cell carcinoma of the oral tongue
DK Zanoni, JC Migliacci, B Xu, N Katabi, PH Montero, I Ganly, JP Shah, ...
JAMA Otolaryngology–Head & Neck Surgery 143 (6), 555-560, 2017
The effects of brain-derived neurotrophic factor (BDNF) administration on kindling induction, Trk expression and seizure-related morphological changes
B Xu, B Michalski, RJ Racine, M Fahnestock
Neuroscience 126 (3), 521-531, 2004
Outcome of large noninvasive follicular thyroid neoplasm with papillary-like nuclear features
B Xu, G Tallini, T Scognamiglio, BR Roman, RM Tuttle, RA Ghossein
Thyroid 27 (4), 512-517, 2017
Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of MED12 and RBM10 as Novel Thyroid Cancer Genes Associated with Tumor …
T Ibrahimpasic, B Xu, I Landa, S Dogan, S Middha, V Seshan, S Deraje, ...
Clinical Cancer Research 23 (19), 5970-5980, 2017
Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets
E Rosenbaum, B Jadeja, B Xu, L Zhang, NP Agaram, W Travis, S Singer, ...
Modern Pathology 33 (4), 591-602, 2020
A contemporary review of machine learning in otolaryngology–head and neck surgery
MG Crowson, J Ranisau, A Eskander, A Babier, B Xu, RR Kahmke, ...
The Laryngoscope 130 (1), 45-51, 2020
DNA methylation-based classification of sinonasal undifferentiated carcinoma
S Dogan, V Vasudevaraja, B Xu, J Serrano, RN Ptashkin, HJ Jung, ...
Modern Pathology 32 (10), 1447-1459, 2019
Frequent IDH2 R172 mutations in undifferentiated and poorly‐differentiated sinonasal carcinomas
S Dogan, DJ Chute, B Xu, RN Ptashkin, R Chandramohan, ...
The Journal of pathology 242 (4), 400-408, 2017
PD-L1 immunohistochemistry assay concordance in urothelial carcinoma of the bladder and hypopharyngeal squamous cell carcinoma
A Hodgson, E Slodkowska, A Jungbluth, SK Liu, D Vesprini, ...
The American journal of surgical pathology 42 (8), 1059-1066, 2018
Molecular alterations in thyroid carcinoma
MRH Al Rasheed, B Xu
Surgical pathology clinics 12 (4), 921-930, 2019
Continuous infusion of neurotrophin-3 triggers sprouting, decreases the levels of TrkA and TrkC, and inhibits epileptogenesis and activity-dependent axonal growth in adult rats
B Xu, B Michalski, RJ Racine, M Fahnestock
Neuroscience 115 (4), 1295-1308, 2002
PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities
N Katabi, B Xu, AA Jungbluth, L Zhang, SY Shao, J Lane, R Ghossein, ...
Histopathology 72 (2), 285-293, 2018
Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups
C Parra-Herran, J Lerner-Ellis, B Xu, S Khalouei, D Bassiouny, M Cesari, ...
Modern Pathology 30 (12), 1748-1759, 2017
International medullary thyroid carcinoma grading system: a validated grading system for medullary thyroid carcinoma
B Xu, TL Fuchs, S Ahmadi, M Alghamdi, B Alzumaili, MA Bani, E Baudin, ...
Journal of Clinical Oncology 40 (1), 96-104, 2022
The system can't perform the operation now. Try again later.
Articles 1–20